tiprankstipranks

Martin Shkreli Insider Profile

18 Followers
Martin Shkreli, Fmr Officer Dir 10% Sharehldr at Travere Therapeutics, holds 2.08M shares in Humanigen (Ticker: HGENQ), holds 1.77M shares in Travere Therapeutics (Ticker: TVTX). Most recently, Martin Shkreli Sold ― shares of Humanigen on Aug 29, 2016 for an estimated value of 6.89M.
tipranks
Martin Shkreli

Martin Shkreli
Travere Therapeutics (TVTX)
Fmr Officer Dir 10% Sharehldr

Ranked #92,495 out of 98,564 Corporate Insiders

Profitable Transactions

26%
8 out of 31 Profitable Transactions

Average Return

-18.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
99.78%
0.22%
A breakdown of Martin Shkreli's holdings

Insider Roles

Travere Therapeutics
(TVTX)
Fmr Officer Dir 10% Sharehldr
Humanigen
(HGENQ)
CEO, Director, Ten Percent Owner
Roles that Martin Shkreli holds in companies

Most Profitable Insider Trade

Stock:
Humanigen
(HGENQ)
Rating:Informative Buy
Date:Nov 18, 2015 - Nov 18, 2016
Return:+78.20%
The most profitable trade made by Martin Shkreli

Martin Shkreli's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Travere Therapeutics
Nov 23, 2014
Fmr Officer Dir 10% Sharehldr
Informative Sell
10.36M
$10.13M
Humanigen
Aug 29, 2016
CEO, Director, Ten Percent Owner
Informative Sell
6.89M
$22.83K
List of latest transactions for each holding click on a transaction to see Martin Shkreli's performance on stock

Martin Shkreli insider profile FAQ

What is the percentage of profitable transactions made by Martin Shkreli?
The percentage of profitable transactions made by Martin Shkreli is 26%.
    What is the average return per transaction made by Martin Shkreli?
    The average return per transaction made by Martin Shkreli is -18.80%.
      What stocks does Martin Shkreli hold?
      Martin Shkreli holds: TVTX, HGENQ stocks.
        What was Martin Shkreli’s latest transaction?
        Martin Shkreli latest transaction was an Informative Sell of $6.89M.
          What was Martin Shkreli's most profitable transaction?
          Martin Shkreli’s most profitable transaction was an Informative Buy of HGENQ stock on November 18, 2015. The return on the trade was 78.20%.
            What is Martin Shkreli's role in Travere Therapeutics?
            Martin Shkreli's role in Travere Therapeutics is Fmr Officer Dir 10% Sharehldr.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.